ATOS
Atossa Therapeutics, Inc. Common StockRecent alerts on ATOS
All signals →
News
Are Medical Stocks Lagging Alvotech (ALVO) This Year?
14d ago
News
Atossa Therapeutics GAAP EPS of -$1.11
25d ago
SEC filing
ATOS Settles Endoxifen Patent Dispute with Intas, Jina; Preserves Z-Endoxifen Development Rights, PTAB Termination Expected
47d ago
SEC filing
ATOS Reports $0 Revenue, -$0.08 EPS, FDA Rare Pediatric & Orphan Designations for (Z)-Endoxifen in DMD, 2025 Clinical Trials Arena Award
69d ago
SEC filing
ATOS Highlights 2025 Progress in Oncology Trials, Pauses Metastatic Breast Cancer Study, Explores Duchenne Muscular Dystrophy Potential
111d ago
News
Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The Top 50 Healthcare Technology CEOs of 2025
132d ago
News
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
137d ago
News
Atossa Therapeutics shares rise after FDA grants orphan drug designation for soft tissue sarcoma
137d ago
News
Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer
147d ago
Scanner
Unusual volume (z=13.0)
171d ago
Get push alerts for ATOS
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS